291 related articles for article (PubMed ID: 23382494)
1. Efficacy and safety of combined vs. single renin-angiotensin-aldosterone system blockade in chronic kidney disease: a meta-analysis.
Susantitaphong P; Sewaralthahab K; Balk EM; Eiam-ong S; Madias NE; Jaber BL
Am J Hypertens; 2013 Mar; 26(3):424-41. PubMed ID: 23382494
[TBL] [Abstract][Full Text] [Related]
2. Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis.
Currie G; Taylor AH; Fujita T; Ohtsu H; Lindhardt M; Rossing P; Boesby L; Edwards NC; Ferro CJ; Townend JN; van den Meiracker AH; Saklayen MG; Oveisi S; Jardine AG; Delles C; Preiss DJ; Mark PB
BMC Nephrol; 2016 Sep; 17(1):127. PubMed ID: 27609359
[TBL] [Abstract][Full Text] [Related]
3. The effect of renin-angiotensin-aldosterone system blockers on the progression of chronic kidney disease in hypertensive elderly patients without proteinuria: PROERCAN study. Rationale and design.
García-Prieto AM; Verdalles Ú; de José AP; Verde E; Arroyo D; Aragoncillo I; Linares T; Barbieri D; Goicoechea M
Hipertens Riesgo Vasc; 2020; 37(3):101-107. PubMed ID: 32156479
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of astragalus combined with renin-angiotensin-aldosterone system blockers in the treatment of stage III diabetic nephropathy: a systematic review and meta-analysis.
Lin YQ; Yu F; Chen HJ; Deng YR; Lin J; Xu Y; Zheng X; Zhang JW; Liu JF
Ren Fail; 2024 Dec; 46(2):2359033. PubMed ID: 38836372
[TBL] [Abstract][Full Text] [Related]
5. The LIFT trial: study protocol for a double-blind, randomised, placebo-controlled trial of K
Murphy D; Ster IC; Kaski JC; Anderson L; Banerjee D
BMC Nephrol; 2021 Jul; 22(1):254. PubMed ID: 34229607
[TBL] [Abstract][Full Text] [Related]
6. Renin-angiotensin II-aldosterone system blockers and time to renal replacement therapy in children with CKD.
Abraham AG; Betoko A; Fadrowski JJ; Pierce C; Furth SL; Warady BA; Muñoz A
Pediatr Nephrol; 2017 Apr; 32(4):643-649. PubMed ID: 27826732
[TBL] [Abstract][Full Text] [Related]
7. Renin-angiotensin-aldosterone system blockers effect in chronic kidney disease progression in hypertensive elderly patients without proteinuria: PROERCAN trial.
García-Prieto AM; Verdalles Ú; de José AP; Arroyo D; Aragoncillo I; Barbieri D; Camacho RE; Goicoechea M
Hipertens Riesgo Vasc; 2024; 41(2):95-103. PubMed ID: 38508877
[TBL] [Abstract][Full Text] [Related]
8. Management of Hyperkalemia in Renin-Angiotensin-Aldosterone System Inhibitor: Strategies to Maintain Chronic Kidney Disease Patients with Type II Diabetes on Therapy.
Mahmud HA; Palmer BF
Cardiorenal Med; 2024; 14(1):191-201. PubMed ID: 38513618
[TBL] [Abstract][Full Text] [Related]
9. Treatment effects of renin-angiotensin aldosterone system blockade on kidney failure and mortality in chronic kidney disease patients.
Vejakama P; Ingsathit A; McKay GJ; Maxwell AP; McEvoy M; Attia J; Thakkinstian A
BMC Nephrol; 2017 Nov; 18(1):342. PubMed ID: 29187194
[TBL] [Abstract][Full Text] [Related]
10. Urinary Biomarkers and Kidney Injury in VA NEPHRON-D: Phenotyping Acute Kidney Injury in Clinical Trials.
Kiernan EA; Hu D; Philbrook HT; Ix JH; Bonventre JV; Coca SG; Moledina DG; Fried LF; Shlipak MG; Parikh CR
Am J Kidney Dis; 2024 Feb; 83(2):151-161. PubMed ID: 37726051
[TBL] [Abstract][Full Text] [Related]
11. Clinical Outcomes of Renin-Angiotensin-Aldosterone Blockade in Patients With Advanced Chronic Kidney Disease: A Systematic Review and Meta-analysis.
Vendeville N; Lepage MA; Festa MC; Mavrakanas TA
Can J Cardiol; 2024 Mar; ():. PubMed ID: 38458564
[TBL] [Abstract][Full Text] [Related]
12. Incidence, Severity, and Outcomes of AKI Associated with Dual Renin-Angiotensin System Blockade.
Palevsky PM; Zhang JH; Seliger SL; Emanuele N; Fried LF;
Clin J Am Soc Nephrol; 2016 Nov; 11(11):1944-1953. PubMed ID: 27679519
[TBL] [Abstract][Full Text] [Related]
13. Dual inhibition of renin-angiotensin-aldosterone system and endothelin-1 in treatment of chronic kidney disease.
Komers R; Plotkin H
Am J Physiol Regul Integr Comp Physiol; 2016 May; 310(10):R877-84. PubMed ID: 27009050
[TBL] [Abstract][Full Text] [Related]
14. Diabetes and drug-associated hyperkalemia: effect of potassium monitoring.
Raebel MA; Ross C; Xu S; Roblin DW; Cheetham C; Blanchette CM; Saylor G; Smith DH
J Gen Intern Med; 2010 Apr; 25(4):326-33. PubMed ID: 20087674
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic update on oral potassium exchange resin use in chronic kidney disease patients: a systematic review of randomized controlled clinical trials.
Gruver J; Al-Makki A; Shepler B
J Pharm Pharm Sci; 2023; 26():11892. PubMed ID: 38173862
[TBL] [Abstract][Full Text] [Related]
16. The renin-aldosterone axis in kidney transplant recipients and its association with allograft function and structure.
Issa N; Ortiz F; Reule SA; Kukla A; Kasiske BL; Mauer M; Jackson S; Matas AJ; Ibrahim HN; Najafian B
Kidney Int; 2014 Feb; 85(2):404-15. PubMed ID: 23965522
[TBL] [Abstract][Full Text] [Related]
17. Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function.
Luo J; Brunelli SM; Jensen DE; Yang A
Clin J Am Soc Nephrol; 2016 Jan; 11(1):90-100. PubMed ID: 26500246
[TBL] [Abstract][Full Text] [Related]
18. Treatments for Chronic Kidney Disease: A Systematic Literature Review of Randomized Controlled Trials.
Garcia Sanchez JJ; Thompson J; Scott DA; Evans R; Rao N; Sörstadius E; James G; Nolan S; Wittbrodt ET; Abdul Sultan A; Stefansson BV; Jackson D; Abrams KR
Adv Ther; 2022 Jan; 39(1):193-220. PubMed ID: 34881414
[TBL] [Abstract][Full Text] [Related]
19. Renin-Angiotensin-Aldosterone System: From History to Practice of a Secular Topic.
Ksiazek SH; Hu L; Andò S; Pirklbauer M; Säemann MD; Ruotolo C; Zaza G; La Manna G; De Nicola L; Mayer G; Provenzano M
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612843
[TBL] [Abstract][Full Text] [Related]
20. Role of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in hypertension of chronic kidney disease and renoprotection. Study results.
Baltatzi M; Savopoulos Ch; Hatzitolios A
Hippokratia; 2011 Jan; 15(Suppl 1):27-32. PubMed ID: 21897755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
